1
-
3
of
3
results (0.53 seconds)
Sort By:
-
Biosimilars, Part 3: Humira Biosimilar Launches
which began in January with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks ... which began in January with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks ...- Authors: Tony Pistilli, Greg Warren
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Biosimilars, Part 4: The Financial Impact
financial impact that could result from this year’s big event. Savings from biosimilars have accelerated ... financial impact that could result from this year’s big event. prescription drug costs, health care payment ...- Authors: Greg Warren, Tony Pistilli
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Biosimilars, Part 1: A Brief Introduction
United States prescription drug landscape and it’s economics? This article explores those questions as ... Biologics work by targeting specific parts of the body’s immune system to stop a disease from progressing.- Authors: Gregory Warren, Tony Pistilli
- Date: Sep 2023
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability